Key Takeaways
- Tylenol maker Kenvue anticipates lawsuits following President Trump's autism claim.
- The Supreme Court will re-examine presidential power over federal agency officials.
- NVIDIA reports massive cash flow from AI chips, fueling infrastructure investments.
- The Catholic Church seeks to reverse a significant decline in priestly vocations.
Deep Dive
- Tylenol maker Kenvue is bracing for potential lawsuits after President Trump warned acetaminophen causes autism.
- Trump's claim is disputed by scientific advisors and contradicted by inconclusive studies.
- The situation could lead to significant legal challenges for the pharmaceutical company.
- The Supreme Court will reconsider a precedent limiting the president's power to remove federal agency heads.
- The court granted President Trump's request to remove a Federal Trade Commission (FTC) commissioner.
- This review could alter the balance of power between the presidency and independent agencies.
- NVIDIA is generating substantial cash flow from its AI chips, with free cash flow increasing from $6 billion to $72 billion in three years.
- The company is investing this cash into AI infrastructure, including taking stakes in AI startups like Core Weave.
- WSJ tech reporter Sam Schechner notes that these investments may raise concerns about the sustainability of demand.
- The Catholic Church is experiencing a clergy crisis due to a declining number of young men entering the priesthood.
- Factors contributing to this decline include societal choices, the commitment to lifelong celibacy, and a more secular environment.
- Pope Francis is attempting to address this by appealing to potential candidates and engaging with Catholic influencers and youth.